“List of phase III cancer clinical trials, 2017”的意思、由来-开放百科全书

词条

List of phase III cancer clinical trials, 2017

释义

References

{{Refimprove
|date=March 2017}}{{Navigation bar|title = Phase III Clinical Trials by Year|list = 2014 – 2015 – 2016 – 2017}}

compound	cancer type	reference	companies involved
ribociclib	breast cancer	^[1]	Novartis, Astex Pharmaceuticals
bavituximab	non-small cell lung cancer	Peregrine Pharmaceuticals
mirvetuximab soravtansine	ovarian cancer	ImmunoGen
duvelisib	relapsed or refractory CLL/SLL	^[2]	Verastem Oncology

References

1. ^https://www.novartis.com/news/media-releases/novartis-lee011-ribociclib-granted-fda-priority-review-first-line-treatment
2. ^https://clinicaltrials.gov/ct2/show/NCT02004522

1 : Clinical trials related to cancer

随便看

开放百科全书收录14589846条英语、德语、日语等多语种百科知识，基本涵盖了大多数领域的百科知识，是一部内容自由、开放的电子版国际百科全书。